Facebook
Instagram
Twitter
YouTube
RSS Feed
LinkedIn
Flickr
California's Stem Cell Agency
California Institute for Regenerative Medicine
For Researchers
Funding Opportunities
All Funding Opportunities
COVID-19
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
Grants
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
Clinical Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
Research Resources
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
2019-2020 Report
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Leadership
Our History
Annual Reports
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
Search form
Search
You are here
Home
› Stanford University
Stanford University
Total Awards:
142
Award Value:
$386,099,274
Major Facility Name:
Lorry I. Lokey Stem Cell Research Building
Institution type:
Not for profit
Short Name:
Stanford
Share
Awards to the Institution
Program
Investigator
Award Title
Award Value
Quest - Discovery Stage Research Projects
Kyle Loh
Towards hepatocyte cell replacement therapy: developing a renewable source of human hepatocytes from pluripotent stem cells
$1,968,456
Tools and Technologies II
Theo Palmer
Development of small molecule screens for autism using patient-derived iPS cells
$1,797,606
Therapeutic Translational Research Projects
Theodore Leng
NeuBright, a purified allogeneic cell therapy product for treatment of Dry Age-related Macular Degeneration
$4,235,758
Basic Biology III
Sean Wu
Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells
$1,260,537
Early Translational III
Bertha Chen
Autologous iPSC Therapy for Urinary Incontinence
$4,715,738
Basic Biology IV
Alexander Dunn
Role of mechanical signaling in stem cell self-renewal and differentiation
$1,062,998
Disease Team Therapy Development III
Irving Weissman
Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors
$6,505,568
Shared Labs
Renee Reijo Pera
The Stanford University Center for Human Embryonic Stem Cell Research and Education
$2,439,590
Early Translational II
Michele Calos
Stem Cell Therapy for Duchenne Muscular Dystrophy
$2,267,261
SPARK
Paul Utz
Stem Cell and Regenerative Medicine- Summer Research Internship
$380,827
SEED Grant
Krishna Shenoy
Technology for hESC-Derived Cardiomyocyte Differentiation and Optimization of Graft-Host Integration in Adult Myocardium
$572,891
Quest - Discovery Stage Research Projects
Rosa Bacchetta
GENE EDITING FOR FOXP3 IN HUMAN HSC
$984,228
SEED Grant
Phillip Yang
In Vivo Molecular Magnetic Resonance Imaging of Human Embryonic Stem Cells in Murine Model of Myocardial Infarction
$629,952
Conference
Hank Greely
Stem Cell Policy: Understanding the Scientific and Legal Challenges Ahead
$5,838
Comprehensive Grant
Julie Baker
Functional Genomic Analysis of Chemically Defined Human Embryonic Stem Cells
$2,518,303
Conference II
Samuel Strober
Third International Workshop on Clinical Tolerance
$29,500
Transplantation Immunology
Robert Negrin
Regulatory T cell induced tolerance to ESC transplantation
$1,382,658
Transplantation Immunology
Judith Shizuru
Purified allogeneic hematopoietic stem cells as a platform for tolerance induction
$1,233,275
Conference II
Joseph Wu
2018 Stanford Drug Discovery and Stem Cell Technology Conference
$15,000
Tools and Technologies II
Sarah Heilshorn
Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels
$600,695
Clinical Trial Stage Projects
Everett Meyer
Induction of Tolerance by Combinatorial Therapy w/ Donor Stem Cells and Expanded Recipient Treg cells in HLA-mismatched Kidney Transplant Recipients
$11,955,585
Research Training II
Theo Palmer
Stanford CIRM Training Program
$7,017,629
Disease Team Therapy Development - Research
Judith Shizuru
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants
$19,068,382
Basic Biology IV
Michelle Monje
Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain
$1,264,248
Research Leadership
Hiromitsu Nakauchi
Generation of functional cells and organs from iPSCs
$5,426,810
Genomics Centers of Excellence Awards (R)
Michael Snyder
Center of Excellence for Stem Cell Genomics - Stanford
$22,787,914
Disease Team Research I
Alfred Lane
iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa
$11,039,208
Therapeutic Translational Research Projects
Albert Wong
2nd Generation Vaccine for the Treatment of Glioblastoma
$2,929,889
SEED Grant
Calvin Kuo
Differentiation of Human Embryonic Stem Cells to Intestinal Fates
$554,176
Quest - Discovery Stage Research Projects
Roel Nusse
Preclinical development of human hepatocyte progenitor cells for cell therapy
$1,651,211
SEED Grant
Susan McConnell
Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease
$607,363
Conference
Joseph Wu
Cardiovascular Tissue Engineering Symposium
$25,000
Comprehensive Grant
Theo Palmer
Immunology of neural stem cell fate and function
$2,396,000
Late Stage Preclinical Projects
Gary Steinberg
Intraparenchymal NR1 Stem Cell Therapy for Chronic Subcortical Ischemic Stroke
$5,300,000
Transplantation Immunology
Kenneth Weinberg
Engineered immune tolerance by Stem Cell-derived thymic regeneration
$1,271,729
Tools and Technologies III
James Dunn
Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction
$772,098
Tools and Technologies II
Brian Rutt
Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters
$1,833,348
Clinical Trial Stage Projects
Judith Shizuru
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants
$1,113,504
Disease Team Therapy Planning I
Judith Shizuru
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants
$90,147
Disease Team Therapy Development - Research
Joseph Wu
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure
$19,060,330
Creativity Awards
Paul Utz
SIMR Program: Stem Cell & Developmental Biology Research Internships
$340,611
Basic Biology V
Xinnan Wang
Misregulated Mitophagy in Parkinsonian Neurodegeneration
$1,174,943
Basic Biology I
Susan McConnell
Identification and characterization of human ES-derived DA neuronal subtypes
$1,404,853
Tools and Technologies III
Anthony Oro
A Chromatin Context Tool for Predicting iPS Lineage Predisposition and Tissue Graftability
$1,391,125
Disease Team Research I
Gary Steinberg
Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke
$17,244,851
Conference II
Joseph Wu
Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference
$7,500
SEED Grant
John Cooke
EC regeneration in cerebrovascular ischemia: role of NO
$476,995
Quest - Discovery Stage Research Projects
Matthew Porteus
Genome Editing to Correct Cystic Fibrosis Mutations in Airway Stem Cells
$1,968,456
SEED Grant
Mark Kay
Novel vectors for gene transfer into human ES cells
$574,737
Clinical Trial Stage Projects
Samuel Strober
Induction of Tolerance to Combined Kidney and Hematopoietic Progenitor Cell Transplants from HLA Haplotype Matched Living Donors
$6,653,266
Comprehensive Grant
Christopher Zarins
Engineering a Cardiovascular Tissue Graft from Human Embryonic Stem Cells
$2,454,490
Disease Team Planning
Thomas Rando
Stem Cell Therapy for Muscular Dystrophy
$0
Late Stage Preclinical Projects
Matthew Porteus
Genome Editing of Autologous Hematopoietic Stem Cells to Treat Sickle Cell Disease
$4,849,363
New Faculty I
Anne Brunet
Molecular mechanisms involved in adult neural stem cell maintenance
$2,348,435
Clinical Trial Stage Projects
Crystal Mackall
Phase 1 Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Adults with Recurrent or Refractory B Cell Malignancies
$11,034,982
Tools and Technologies II
Irving Weissman
Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs
$1,463,814
Late Stage Preclinical Projects
Rosa Bacchetta
IND-enabling activities for a Phase 1 Study of Autologous CD4LVFOXP3 T Cells in Subjects with IPEX Syndrome
$5,002,496
Disease Team Therapy Planning I
Albert Wong
Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma
$109,750
Basic Biology IV
Howard Chang
Long noncoding RNAs for pluripotency and cell fate commitment
$1,386,627
New Faculty Physician Scientist
Alan Cheng
Enhancing hair cell regeneration in mouse and human inner ear
$3,088,525
Basic Biology V
Helen Blau
Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging
$1,175,357
Basic Biology I
Julien Sage
The retinoblastoma (RB) gene family in cellular reprogramming
$1,357,085
Tools and Technologies III
Fan Yang
Injectable Macroporous Matrices to Enhance Stem Cell Engraftment and Survival
$1,434,235
Disease Team Research I
Irving Weissman
Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells
$18,759,276
Inception - Discovery Stage Research Projects
Phillip Yang
Activation of patient-specific endogenous myocardial repair through the exosomes generated from the hypoxic iPSC-derived cardiomyocytes (iCMs).
$234,619
SEED Grant
Aaron Hsueh
Patient-specific cells with nuclear transfer
$629,653
Conference
Julien Sage
3rd International RB conference
$10,000
SEED Grant
Julien Sage
Functions of RB family proteins in human embryonic stem cells
$498,609
Tool Translational Research Projects
Joseph Wu
A Novel, Robust and Comprehensive Predictive Tool Using Human Disease-Specific Induced Pluripotent Stem Cells for Preclinical Drug Screening
$975,000
Comprehensive Grant
Renee Reijo Pera
Human oocyte development for genetic, pharmacological and reprogramming applications
$2,298,411
Therapeutic Translational Research Projects
Anthony Oro
DEBCT: Genetically Corrected, Induced Pluripotent Cell-Derived Epithelial Sheets for Definitive Treatment of Dystrophic Epidermolysis Bullosa
$5,107,353
New Faculty I
Howard Chang
Noncoding RNAs in Cell Fate Determination
$2,985,894
Therapeutic Translational Research Projects
Bertha Chen
Autologous iPSC-derived smooth muscle cell therapy for treatment of urinary incontinence
$5,977,155
Tools and Technologies II
Marius Wernig
Cellular tools to study brain diseases affecting synaptic transmission
$1,664,382
Progression Award - Discovery Stage Research Projects
Hiromitsu Nakauchi
Using metabolic pausing for maintaining stable and high-quality pluripotent stem cells
$208,422
Disease Team Therapy Planning I
Robert Robbins
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure
$73,030
Basic Biology IV
Gerald Crabtree
Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch
$1,392,150
New Faculty Physician Scientist
Michelle Monje
White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain”
$2,800,526
Basic Biology V
Marius Wernig
Mechanisms of human induced neuronal cell reprogramming
$1,178,370
Basic Biology I
Helen Blau
Molecular Mechanisms of Reprogramming towards Pluripotency
$1,408,332
Tools and Technologies III
Sarah Heilshorn
Injectable Hydrogels for the Delivery, Maturation, and Engraftment of Clinically Relevant Numbers of Human Induced Pluripotent Stem Cell-Derived Neural Progenitors to the Central Nervous System
$1,347,767
New Cell Lines
Julie Baker
Derivation of hESC Lines with Disease Lesions
$1,404,725
Inception - Discovery Stage Research Projects
Bertha Chen
Autologous iPSC-based therapy for radiation induced bladder injury
$235,836
SEED Grant
Thomas Wandless
Reprogramming Differentiated Human Cells to a Pluripotent State
$380,005
Conference
Thomas Rando
Third Annual Symposium on Regenerative Rehabilitation
$20,000
New Faculty II
Ching-Pin Chang
VEGF signaling in adventitial stem cells in vascular physiology and disease
$3,005,695
Conference II
Joseph Wu
2017 Stanford Drug Discovery and Stem Cell Technology Conference
$2,359
Early Translational I
Jill Helms
Enhancing healing via Wnt-protein mediated activation of endogenous stem cells
$6,464,126
Inception - Discovery Stage Research Projects
Guillem Pratx
Novel metabolic labeling method for tracking stem cells to irradiated salivary glands using PET
$229,227
New Faculty I
Karl Deisseroth
Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny
$2,424,209
Quest - Discovery Stage Research Projects
Katja Weinacht
Regenerative Thymic Tissues as Curative Cell Therapy for Patients with 22q11 Deletion Syndrome
$1,251,720
Basic Biology III
Michael Clarke
USP16 controls stem cell number: implications for Down Syndrome
$1,263,826
Discovery Research Projects
Helen Blau
Application of PGE2/BPV, a muscle stem cell targeting therapeutic, to the treatment of COVID-19 associated diaphragm atrophy
$149,996
Training Grant I-1
Michael Longaker
Stanford CIRM Training Program
$3,035,282
Basic Biology IV
Roel Nusse
Asymmetric stem cell division oriented by a local self-renewing signal
$1,039,058
Tissue Collection for Disease Modeling
Joachim Hallmayer
Induced pluripotent stem cells from children with autism spectrum disorders
$530,265
Basic Biology V
Gary Steinberg
Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery
$1,178,370
Basic Biology II
Steven Artandi
Self-renewal and senescence in iPS cells derived from patients with a stem cell disease
$931,285
Tools and Technologies III
Irving Weissman
Identification and isolation of transplantable human hematopoietic stem cells from pluripotent cell lines; two steps from primitive hematopoiesis to transplantable definitive cells, and non-toxic conditioning of hosts for hematopoeitic stem cell transp...
$1,271,952
New Cell Lines
Michele Calos
Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses
$1,406,875
Inception - Discovery Stage Research Projects
Philip Beachy
Curing bladder cancer by replacing corrupted urothelium with differentiated hES cells
$210,906
SEED Grant
Kenneth Weinberg
Embryonic stem cell-derived thymic epithelial cells
$628,793
Conference
Fan Yang
2014 Materials Research Society (MRS) Spring Meeting: Symposium Y: Biomaterials for Biomolecule Delivery and Understanding Cell-Niche Interactions
$10,000
Comprehensive Grant
Irving Weissman
Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells
$2,471,386
Patent Assistance Fund Awards
Katharine Ku
Funding for Patent Applications for CIRM-funded Inventions out of Stanford University
$3,525
Shared Labs
Vittorio Sebastiano
The Stanford University Center for Human Embryonic Stem Cell Research and Education
$3,434,600
Inception - Discovery Stage Research Projects
Hiromitsu Nakauchi
Optimizing self-renewal signaling kinetics to stabilize ex vivo hematopoietic stem cell expansion
$210,906
New Faculty I
Joanna Wysocka
Trithorax and Polycomb methyltransferase complexes in cell fate determination.
$2,373,903
Quest - Discovery Stage Research Projects
Philip Beachy
Pluripotent stem cell-derived bladder epithelial progenitors for definitive cell replacement therapy of bladder cancer
$1,265,436
Basic Biology III
Aaron Hsueh
Correlated time-lapse imaging and single cell molecular analysis of human embryo development
$1,259,733
Discovery Research Projects
Albert Wong
Identifying HLA Class I Restricted Peptides That Induce CD8+ T Cells Against SARS-CoV-2
$249,999
Early Translational III
Joseph Wu
Heart Repair with Human Tissue Engineered Myocardium
$4,396,738
Basic Biology IV
Anne Brunet
Energy metabolism and aging pathways in human stem cell reprogramming and differentiation
$1,414,044
Tissue Collection for Disease Modeling
Joseph Wu
Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases
$1,291,832
Major Facilities
John Hennessy
Stanford SIM1 Building
$43,578,000
Basic Biology II
Garry Nolan
Kinase signaling analysis of iPS cell reprogramming and differentiation
$1,343,100
Tools and Technologies III
Joseph Wu
Macaca mulatta as advanced model for predictive preclinical testing of engineered cardiac autografts and allografts
$1,689,744
New Cell Lines
Michael Longaker
Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts
$1,406,636
Inception - Discovery Stage Research Projects
Jeffrey Goldberg
Embryonic Stem Cells for Corneal Endothelial Degeneration
$235,836
SEED Grant
Joseph Wu
In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity
$623,634
Conference
Joseph Wu
Cardiovascular Regenerative Medicine Symposium
$9,000
Comprehensive Grant
Stefan Heller
Generation of inner ear sensory cells from human ES cells toward a cure for deafness
$2,330,371
Inception - Discovery Stage Research Projects
Helen Blau
Prodrug innovation to target muscle stem cells and enhance muscle regeneration
$235,834
Tools and Technologies I
Helen Blau
Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells
$949,608
Quest - Discovery Stage Research Projects
Helen Blau
Stimulating endogenous muscle stem cells to counter muscle atrophy
$2,198,687
Tools and Technologies II
Michele Calos
Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation
$1,592,897
Quest - Discovery Stage Research Projects
Alan Cheng
Modulation of the Wnt pathway to restore inner ear function
$1,394,870
Basic Biology III
Joanna Wysocka
Enhancer-mediated gene regulation during early human embryonic development
$1,420,618
Progression Award - Discovery Stage Research Projects
Helen Blau
Stimulating endogenous muscle stem cells to counter muscle wasting
$237,060
Early Translational III
Helen Blau
Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients
$1,825,666
Basic Biology IV
Michael Cleary
Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells
$1,244,455
Early Translational IV
Michele Calos
Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B
$1,876,253
Disease Team Planning
Robert Robbins
{REDACTED} Cardiovascular Regenerative Team
$25,119
Basic Biology II
Aaron Hsueh
Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation
$1,309,018
Preclinical Development Awards
Matthew Porteus
Pre-clinical development of gene correction therapy of hematopoietic stem cells for SCID-X1
$874,877
New Cell Lines
Renee Reijo Pera
Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype
$1,409,243
Quest - Discovery Stage Research Projects
Hiromitsu Nakauchi
Novel Rejuvenated T Cell Immunotherapy for Lung Cancer
$1,968,456
SEED Grant
Joanna Wysocka
Role of Chromatin Modifiers in Regulating Human Embryonic Stem Cell Pluripotency
$629,952
Conference
Thomas Rando
Keystone Symposia, 'The Life of a Stem Cell: From Birth to Death'
$50,000
Comprehensive Grant
Roel Nusse
Guiding the developmental program of human embryonic stem cells by isolated Wnt factors
$1,710,462
Quest - Discovery Stage Research Projects
Mark Mercola
Multipotent Cardiovascular Progenitor Regeneration of the Myocardium after MI
$1,809,234
Transplantation Immunology
Christopher Contag
Engineering Embryonic Stem Cell Allografts for Operational Tolerance
$1,411,338
Total:
$386,099,275.00